Evaxion A (EVAX) Current Assets (2019 - 2025)
Evaxion A's (EVAX) quarterly Current Assets came in at $24.9 million in Q4 2025, up 184.1% YoY from $8.8 million in Q4 2024, and up 36.99% on a QoQ basis from $18.2 million in Q2 2025.
Evaxion A (EVAX) Current Assets (2019 - 2025) Analysis & Trends
Evaxion A (EVAX) has 7 years of Current Assets data on file, last reported at $24.9 million in Q4 2025.
- Quarterly Current Assets rose 184.1% year-over-year to $24.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.9 million (up 184.1% YoY) and the FY2025 annual result came in at $24.9 million, up 184.1% from the prior year.
- Current Assets improved to $24.9 million in Q4 2025, from $18.2 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $35.4 million in Q1 2022 to a low of $8.4 million in Q4 2023.
- A 5-year average of $20.8 million and a median of $18.2 million in 2025 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2021 — Current Assets jumped 216.94% — and 2023, when it sank 60.16%.
- Tracing EVAX's Current Assets over 5 years: stood at $34.7 million in 2021, then sank by 51.06% to $17.0 million in 2022, then tumbled by 50.84% to $8.4 million in 2023, then grew by 4.97% to $8.8 million in 2024, then soared by 184.1% to $24.9 million in 2025.
- The last three Current Assets figures came in at $24.9 million (Q4 2025), $18.2 million (Q2 2025), and $8.8 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.84 Bn | 131.99 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.48 Bn | 78.49 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.15 Bn | 55.01 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.54 Bn | 10.14 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.22 Bn | 26.38 Bn | - | 1.76 Bn |
| 10 | Evaxion A | 27.69 Mn | 27.69 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.90 Mn |
| Jun 30, 2025 | 18.18 Mn |
| Dec 31, 2024 | 8.77 Mn |
| Jun 30, 2024 | 10.70 Mn |
| Dec 31, 2023 | 8.35 Mn |
| Jun 30, 2023 | 11.37 Mn |
| Dec 31, 2022 | 16.99 Mn |
| Jun 30, 2022 | 28.53 Mn |
| Mar 31, 2022 | 35.38 Mn |
| Dec 31, 2021 | 34.71 Mn |
| Sep 30, 2021 | 16.32 Mn |
| Jun 30, 2021 | 23.43 Mn |
| Mar 31, 2021 | 32.49 Mn |
| Dec 31, 2020 | 10.95 Mn |
| Dec 31, 2019 | 10.96 Mn |